Epigenetic advances in rheumatic heart disease

Area of Science:

• Cardiovascular Medicine
• Immunology
• Genetics

Background:

• Rheumatic heart disease (RHD) is an autoimmune condition following group A streptococcus (GAS) infection.
• Epigenetic dysregulation, including DNA methylation, histone modification, non-coding RNAs (ncRNAs), and chromatin remodeling, is central to RHD pathogenesis.
• Research is shifting towards understanding RHD etiologies beyond late-stage diagnosis and treatment.

Purpose of the Study:

• To systematically review recent advancements in the epigenetic research of RHD.
• To elucidate the intricate interactions between RHD and the four core epigenetic mechanisms.
• To highlight potential biomarkers for early RHD diagnosis and therapeutic interventions.

Main Methods:

• Systematic literature review of epigenetic studies related to RHD.
• Analysis of research focusing on DNA methylation, histone modification, ncRNAs, and chromatin remodeling in RHD.
• Synthesis of findings to identify emerging research directions and limitations.

Main Results:

• Abnormalities in DNA methylation, histone modification, ncRNAs, and chromatin remodeling are significantly implicated in RHD development.
• Epigenetic mechanisms offer promising avenues for identifying early diagnostic biomarkers.
• Current research highlights the need for comprehensive multi-omics approaches and advanced techniques.

Conclusions:

• Epigenetic dysregulation plays a critical role in RHD pathogenesis, presenting therapeutic targets.
• Future research should integrate multi-omics data and advanced technologies for improved RHD prevention and management.
• Addressing limitations of small-sample studies is crucial for advancing RHD epigenetic research.